Metraipolis › archive › dc_8e0865ee4529
The novel antidiabetic medications on diabetic retinopathy: relevant molecular mechanisms, advancing diagnostic innovations, and therapeutic implications — Europe PMC PMID:41608415
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41608415
- DOI
- 10.3389/fmed.2025.1670643
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T20:50:16.888Z
- SHA-256 of the archived text
42e13da5dcd085aa62066a077de839e885af8f3dfc0b1ff43f2aa9043a10fe42- Stable URL of this page
https://metraipolis.com/documento/dc_8e0865ee4529
How to cite
The novel antidiabetic medications on diabetic retinopathy: relevant molecular mechanisms, advancing diagnostic innovations, and therapeutic implications — Europe PMC PMID:41608415 — Europe PMC (en), https://europepmc.org/article/MED/41608415 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8e0865ee4529 (Metraipolis archive dc_8e0865ee4529, sha256 42e13da5dcd085aa62066a077de839e885af8f3dfc0b1ff43f2aa9043a10fe42)
BibTeX
@misc{dc8e0865ee4529,
title = {The novel antidiabetic medications on diabetic retinopathy: relevant molecular mechanisms, advancing diagnostic innovations, and therapeutic implications — Europe PMC PMID:41608415},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41608415},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8e0865ee4529; sha256 42e13da5dcd085aa62066a077de839e885af8f3dfc0b1ff43f2aa9043a10fe42},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608415. Agents can read the archived copy with the MCP tool read_document.